Find Academic Supervisors

Alexis Battle is an Associate Professor at Johns Hopkins University with appointments in Biomedical Engineering , Computer Science , and Genetic Medicine (secondary). She directs the Malone Center for Engineering in Healthcare and serves as Deputy Director of the Data Science and AI Institute . Educated at Stanford University (PhD in Computer Science, 2013), Battle transitioned to academia after leadership roles at Google. Research Focus: Battle’s work bridges genomics and machine learning , emphasizing the impact of genetic variation on human health. Her lab develops tools like Watershed to predict functional effects of rare variants, aiming to enhance rare disease diagnosis. Key themes include non-coding DNA analysis , personalized genomics , and systems biology , with applications in cardiovascular disease and neurodegenerative disorders . Publications & Awards: Over 60 peer-reviewed articles in journals like Nature , Science , and Genome Biology , with recent emphasis on single-cell transcriptomics , multiomics integration , and telomere biology . Recipient of the President’s Frontier Award (2022), Microsoft Investigator Fellowship (2019), and Searle Scholar (2016). Scientific Awards: 2022 President’s Frontier Award 2019 Microsoft Investigator Fellowship 2019 Johns Hopkins Discovery Award 2017 Johns Hopkins Catalyst Award 2016 Searle Scholar Advising & Funding: Mentors 11 PhD students, 3 undergraduates, and postdoctoral fellows. Her research is funded by NIH, Searle Scholars, and institutional grants. The Battle Lab collaborates on projects like the GTEx Consortium , focusing on gene regulation and clinical genomics .

• Genomics
• Machine Learning
• Computational Biology
• +3 more

Bertram Müller-Myhsok is a Research Professor and Research Group Leader at the Max Planck Institute of Psychiatry in Munich, Germany. His research focuses on statistical genetics and transcriptomic data analysis in psychiatric disorders, particularly major depression, PTSD, schizophrenia, and their treatment responses. He integrates machine learning with genetic and clinical data to develop predictive models and stratified treatment approaches. Professional activities include leadership roles in the International Max Planck Research School for Translational Psychiatry and collaborations with institutions like the Institut du Cerveau (Paris) and Bernhard Nocht Institute (Hamburg). His work spans genetic epidemiology, psychiatric genomics, and precision medicine, with over 400 publications in high-impact journals. Key research areas include identifying genetic risk factors for mental disorders, developing polygenic scores, and leveraging omics data to uncover disease mechanisms. He leads projects like Psych-STRATA, a Horizon Europe-funded initiative advancing personalized psychiatry through pharmacogenomics.

• Psychiatric Genetics
• Statistical Genetics
• Transcriptomics
• +3 more

Christopher Conway serves as Associate Professor of Psychology at Fordham University's College of Arts and Sciences, where he directs the Bronx Personality (B-PER) Lab. His research investigates borderline personality disorder, anxiety, depression, and distress tolerance using experience sampling methods and longitudinal designs. The lab examines personality development across key transitions such as romantic breakups and financial strain. 2007 BS in Psychology and Spanish, Duke University 2009 MA in Clinical Psychology, University of California, Los Angeles 2013 PhD in Clinical Psychology, University of California, Los Angeles Conway's work centers on distress tolerance as a protective factor against self-injurious behaviors, momentary personality processes using ecological assessment, and the HiTOP consortium 's dimensional classification of psychopathology. His lab develops quantitative models linking personality dimensions to clinical outcomes, with emphasis on how stressors trigger symptom changes. Recent publications reveal neuroticism's specific association with broadband internalizing symptoms rather than narrowband anxiety or anhedonia. His publications demonstrate consistent focus on transdiagnostic mechanisms and dimensional classification systems . Key trends include validating the HiTOP framework across cultures, examining distress tolerance in substance use contexts across four continents, and developing within-person models of self-injury using registered report methodology. Professional affiliations include: Society for Research on Psychopathology Association for Psychological Science Association for Behavioral and Cognitive Therapies Association for Research in Personality Conway advises multiple graduate students in the B-PER Lab and leads several active studies including MOMENT (Measuring Our Momentary Emotions and Negative Thoughts), DENEM (Daily Experiences of Negative Emotions), and READI (Responses to Emotions And Daily Interactions). His lab participates in the multinational Cross-cultural Addictive Behaviors Study examining distress tolerance across seven countries. All research materials follow open science principles through his OSF repository. The B-PER Lab maintains active research programs examining personality development through: 3-year longitudinal Multiyear Adult Personality Project (MAPP) Cross-cultural Addictive Behaviors Study (CABS) Daily emotion regulation projects using smartphone-based assessments

• Borderline Personality Disorder
• Clinical Psychology
• Distress Tolerance
• +6 more

Sara Hägg is a Senior Lecturer at the Karolinska Institutet , affiliated with the Department of Medical Epidemiology and Biostatistics . She is also a Docent in molecular epidemiology. PhD in Computational Biology (Linköping University, 2009) MSc in Molecular Biology (Stockholm University, 2003) BSc in Computer Science (Stockholm University, 2003) Her research focuses on human biological aging , including measurement of aging markers (telomere length, epigenetic clocks, frailty index), causal pathway analysis, and identification of geroprotectors for age-related diseases. She utilizes longitudinal twin studies (SATSA, GENDER, HARMONY), UK Biobank, and Swedish cohorts with methods like Mendelian randomization and genome-wide analyses . Recent articles demonstrate trends in epidemiological aging research , with emphasis on cardiovascular aging , neurological disease interactions , metabolic profiling , and epigenetic clocks . Her work often involves multivariable modeling and cross-cohort validation . Leadership roles include Director of LifeGene Core Facility (2024-) and Founding Board Member of the Nordic Aging Society (2023-). She serves on expert groups for the Swedish Twin Registry and Strategic Research Area in Epidemiology and Biostatistics .

• Epidemiology
• Gerontology
• Medical Genetics and Genomics
• +3 more

Prof. Dr. Dr. Elisabeth Binder is the Director of the Max Planck Institute of Psychiatry and leads the Max Planck Research Group "Genes and Environment" in Munich, Germany. Her research focuses on molecular mechanisms underlying psychiatric disorders, particularly how genetic and environmental factors interact in disease development. Education: Medicine (University of Vienna), Neuroscience (Emory University) Affiliations: Max Planck Institute of Psychiatry, International Max-Planck Research School Translational Psychiatry, Graduate School of Systemic Neuroscience Research Interests: Elisabeth Binder investigates gene-environment interactions in psychiatric disorders, emphasizing early trauma and stress response. Her work employs next-generation sequencing, epigenetic analysis, and induced pluripotent stem cells to identify biological markers for disease prevention and treatment. Scientific Awards: Theodore Reich Young Investigator Award (2010) Max Hamilton Memorial Prize (2012) Eva King-Killam Research Award (2016) Carus Medal (2017) Ron the Kloet Award for Stress Research (2019) Leadership Roles: She is a member of the German National Academy of Sciences (Leopoldina), a Fellow of the American College of Neuropsychopharmacology, and serves on multiple international advisory committees and executive boards in psychiatry and neuroscience.

• Psychiatric Disorders
• Gene-Environment Interactions
• Epigenetics
• +4 more

Lindsey Kent is a Professor at the University of St Andrews' School of Medicine, where she serves as Deputy Head and Director of Admissions. Her research focuses on the biological foundations of psychiatric disorders, particularly ADHD and developmental language disorders. Education: Medicine (Aberdeen University, 1989), PhD (University of Birmingham, 1998) Academic Appointments: Wellcome Trust Fellow (1999), University Lecturer (University of Cambridge, 2003), Reader (University of St Andrews, 2007) Research Trends: Dr. Kent's work explores psychiatric genetics, neurodevelopmental disorders, and molecular mechanisms through genome-wide association studies, exome sequencing, and genetic epidemiology. Key Collaborations: Psychiatric Genomics Consortium, EAGLE Consortium, 23andMe Technical Focus: ATP2C2 gene variants, TNR gene associations, polygenic risk architectures Awards: Fellow of the Higher Education Academy (2000) Academic Contributions: She has directed two Wellcome Trust-funded projects on ADHD genetics and co-authored over 91 peer-reviewed publications, including significant studies in Nature Communications and Human Molecular Genetics . Her editorial roles include serving on the American Journal of Medical Genetics board (2007–2014).

• Psychiatric Genetics
• Neuroscience
• Developmental Disorders
• +4 more

Dr. Qin Li is an Assistant Professor of Genetics at the University of Pennsylvania Perelman School of Medicine, affiliated with the Penn Institute for Immunology & Immune Health (I3H), the Penn Institute for RNA Innovation, and the Penn Center for Genomic Integrity. He earned his BS and PhD in Biological Science and Biochemistry & Molecular Biology from Peking University, followed by postdoctoral training at Stanford University. Education : BS (Peking University, 2009), PhD (Peking University, 2014) Dr. Li’s research focuses on the ADAR1-dsRNA-MDA5 axis, exploring how RNA editing mediates self/non-self discrimination in the immune system. His work connects RNA editing quantitative trait loci (edQTLs) to inflammatory disease heritability and develops computational/experimental tools for RNA editing and sensing. Recent publications highlight his contributions to understanding RNA editing’s role in autoimmune diseases, CRISPR-based regulatory principles, and novel RNA ligand engineering. He mentors PhD and Master’s students in Bioengineering, Cell and Molecular Biology, and related programs.

• RNA Editing
• Immunology
• Genetics
• +3 more

Karin Coifman is a Professor and Chair at Kent State University's Department of Psychological Sciences. She holds a Ph.D. from Columbia University (2008) and specializes in clinical psychology with a focus on emotion regulation, stress, and psychopathology. Her research examines emotion processing and regulation in relation to mental health adjustments during acute and chronic stress. This includes studying resilience, mental illness development, and the role of psychophysiological and behavioral indices in emotion regulation. She leads the Kent Clinical Affective Science Lab and frequently teaches courses in Psychological Interventions and Introduction to Psychotherapy. Dr. Coifman's recent publications analyze pandemic response behaviors, emotion differentiation, and gene-environment interactions in affective disorders. Her work combines experimental methodologies with community and clinical populations. Labs/Teams: Kent Clinical Affective Science Lab

• Emotion Regulation
• Psychopathology
• Stress and Coping
• +4 more

Professor Moritz Rossner serves as Head of the Department of Molecular and Behavioral Neurobiology at the Department of Psychiatry and Psychotherapy, Faculty of Medicine, Ludwig-Maximilians-Universität München (LMU). His research integrates molecular and behavioral approaches to understand the neurobiological underpinnings of psychiatric disorders, particularly schizophrenia and bipolar disorder. Rossner's research interests focus on molecular neurobiology and behavioral analysis using mouse models. His laboratory employs advanced techniques including mouse genetics , behavioral phenotyping , biosensors , next-generation sequencing , and transcriptomics to investigate psychiatric risk genes and pathways. His work bridges cellular and molecular mechanisms with behavioral outcomes, particularly in schizophrenia and bipolar disorder research. Analysis of Rossner's 15 most recent publications (2025) reveals a strong focus on precision psychiatry , neuroimaging biomarkers , and genetic mechanisms underlying psychiatric disorders. His research increasingly incorporates multimodal approaches combining neuroimaging, genomics, and clinical phenotyping to develop biologically informed diagnostic and treatment frameworks. Key themes include blood-brain barrier dysfunction in schizophrenia, inflammatory contributions to symptom severity, and pathway-specific polygenic scores for treatment prediction. Rossner leads the Molecular & Behavioural Neurobiology working group at LMU's Department of Psychiatry and Psychotherapy, which includes specialized units like the Mouse Behavioral Unit. His research program appears well-funded through multiple collaborative projects focused on understanding the molecular basis of psychiatric disorders and developing novel therapeutic approaches.

• Molecular Neurobiology
• Behavioral Neurobiology
• Mouse Genetics
• +7 more

Karestan C. Koenen is Professor of Psychiatric Epidemiology at the Harvard T.H. Chan School of Public Health and an Associate Member at the Broad Institute of MIT and Harvard . She also serves as Affiliated Faculty at the Harvard University Center for the Environment , advising students in Epidemiology and Social Behavioral Sciences. BA in Economics, Wellesley College MA in Developmental Psychology, Columbia University PhD in Clinical Psychology, Boston University Post-doctoral Fellowship in Psychiatric Epidemiology, Columbia University Dr. Koenen's research focuses on three areas: (1) understanding PTSD resilience, (2) trauma's long-term physical health impacts, and (3) expanding access to evidence-based mental health treatments. Her work bridges genetics, global mental health, and trauma epidemiology, with recent studies on epigenetic aging, cognitive outcomes after trauma, and substance use comorbidities. Her 2025 publications span psychiatric genetics, trauma neurobiology, and women's health, emphasizing machine learning, neuroimaging, and population-level interventions. Current projects include the Broad Trauma Initiative and NIMH-funded training programs. 2025 Junior Faculty Mentoring Award 2021 Pamela Sklar Innovation Award 2017 Distinguished Alumnae Award 2015 Robert S. Laufer Memorial Award Dr. Koenen actively trains graduate students through the Trauma Epidemiology and Population Mental Health Research Group . She integrates advocacy into her work, having testified before Congress and consulted on documentaries about trauma, while publishing in outlets like the Boston Globe and Psychology Today . Her lab collaborates on mental health policy and global trauma research.

• Post-Traumatic Stress Disorder
• Violence
• Trauma
• +5 more

David J. Moore, Ph.D., is a licensed clinical psychologist and Professor of Psychiatry at UC San Diego Health. He co-directs the SDSU/UCSD Joint Doctoral Program (JDP) in Clinical Psychology and leads research at the HIV Neurobehavioral Research Program (HNRP). His work focuses on neurocognitive impairments in individuals with HIV, comorbid mental illness, and substance use disorders, with a special emphasis on technological interventions for medication adherence. Doctorate: Ph.D. in Clinical Psychology (SDSU/UCSD JDP, neuropsychology specialization) Postdoctoral Fellowship: UCSD (serious mental illness) Clinical Internship: West Los Angeles VA Dr. Moore’s research addresses: Neurocognitive complications of HIV infection Intersection of HIV and aging Technological interventions for medication adherence Impact of comorbid psychiatric/substance use disorders on functioning His publications span topics including HIV neurocognitive profiles, syndemic factors in sexual risk behavior, and aging with HIV. Current studies integrate metabolomics, neuroimaging, and behavioral data through NIH-funded grants.

• Neuropsychology
• HIV Neurobehavioral Research
• Neurocognitive Disorders
• +5 more

Ismene Petrakis is a Professor of Psychiatry at Yale School of Medicine and Director of the Mental Health Service Line at VA Connecticut Healthcare System since 2010. She also leads the ACGME-accredited Addiction Psychiatry Residency program at Yale and serves as Principal Investigator for NIAAA- and NIDA-funded training grants . Her clinical and research focus bridges alcohol dependence , comorbid psychiatric disorders , and veterans' health . Research Pillars : Pharmacotherapies for dually diagnosed patients Neurobiological mechanisms of alcoholism PTSD-alcohol comorbidity Genetic risk in substance use Methodological Expertise : Multicenter clinical trials Neurotransmitter system analysis Population-based epidemiology Translational neuroscience Key Publications (2024-2025) : Investigations into GLP1R gene expression in kidney disease Dexmedetomidine for comorbid alcohol-PTSD Cognitive training combinations for alcohol use disorder PTSD treatment effects on neurobiological markers Chronic pain-alcohol use syndemic Collaborative Networks : Yale-Drug use, Addiction, and HIV prevention Research Scholars Neuroscience Research Training Program Collaboration with Department of Anesthesiology

• Alcoholism
• Comorbidity
• Neurobiology
• +5 more

Gerald Quon is an Associate Professor in the Department of Molecular and Cellular Biology at the University of California, Davis. He is affiliated with the Genome Center and participates in multiple graduate programs, including Integrative Genetics and Genomics, Neuroscience, Computer Science, Biostatistics, and Biomedical Engineering. Education: PhD in Computer Science from the University of Toronto (2012) MSc in Biochemistry from the University of Toronto (2006) Research Interests: Dr. Quon applies computational approaches to genetics and genomics problems, focusing on the genetics of human disease , models of cell population dynamics , and neurogenomics . His lab builds neural network models to understand how genetic variation affects disease risk through molecular and cellular phenotypes, with applications to obesity, Alzheimer’s disease, psychiatric disorders, and Rett syndrome. Recent Research Trends: Recent publications highlight work in neuroplasticity , single-cell multimodal analysis , brain evolution , morphological variation modeling , and microbiome-based classification . His team combines sequencing and imaging technologies to model cellular interactions and gene expression dynamics. Scientific Awards: NIH New Innovator Award (2021) Grants & Collaborations: He received NSF funding (2019) for computational tools in single-cell analysis and collaborates across disciplines, including neuroscience, biomedical engineering, and computational biology. His lab develops software like scProjection , siVAE , and scAlign .

• Computational Biology
• Single Cell Genomics
• Epigenomics
• +5 more

Dr. Megan Skelton is a Research Fellow at King’s College London’s Social, Genetic and Developmental Psychiatry Centre (SGDP), affiliated with the Institute of Psychiatry, Psychology and Neuroscience. She holds a PhD in Psychology from King’s College London, funded by the NIHR Maudsley Biomedical Research Centre. Her research focuses on leveraging genetic data and longitudinal medical records to study anxiety, depression, and treatment responses, particularly via genome-wide association studies (GWAS), polygenic scoring, and structural equation modeling. Current projects in Prof. Thalia Eley’s EDIT Lab involve prediction modeling, GWAS meta-analyses, and medical record linkage. Education: BSc Psychology (First Class, University of Leeds), MSc Genes, Environment and Development in Psychology (Distinction, King’s College London). Research experience includes roles at the University of Leeds (2011–2017) and King’s College London (2017–present). Awards include the British Psychological Society Undergraduate Award (2014) and Wellcome Trust Biomedical Vacation Scholarship (2013). Key research themes include anxiety/depression comorbidity, treatment efficacy measurement, and understanding genetic influences on mental health outcomes. Her work contributes to UN Sustainable Development Goal 3 (Good Health & Wellbeing) through advancements in personalized mental health care.

• Mental Health
• Genetics
• Depression
• +3 more

Yaira Zoé Núñez is a Researcher in the Division of Human Genetics at the Yale School of Medicine. Her work focuses on genetic and epidemiological factors underlying substance use disorders, including cannabis, opioid, alcohol, and methamphetamine addictions. She collaborates extensively with the Gelernter Lab and other institutions on large-scale genomic studies. Research Interests: Genetic basis of addictive disorders Multi-ancestry genome-wide association studies (GWAS) Epidemiology of polysubstance use Clinical correlates of substance use disorders Key Collaborations: Works with Prof. Joel Gelernter, Renato Polimanti, and international teams. Recent studies include: Multicenter analysis of gambling disorder in methamphetamine users (2025) Multi-ancestry cannabis use disorder GWAS (2023) Genetic risk loci for opioid use disorder (2022) Labs/Teams: Core member of the Gelernter Lab, contributing to translational research bridging genetics and clinical addiction medicine. Active in collaborative networks analyzing large-scale biomedical data.

• Addictive Disorders
• Genetics
• Substance Use Disorders
• +3 more